Why KORU Medical Systems, Inc.’s (KRMD) Stock Is Down 12.59%

By Jenna Brashear
September 16, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate KORU Medical Systems, Inc. before investing.

In this article, we go over a few key elements for understanding KORU Medical Systems, Inc.’s stock price such as:

  • KORU Medical Systems, Inc.’s current stock price and volume
  • Why KORU Medical Systems, Inc.’s stock price changed recently
  • Upgrades and downgrades for KRMD from analysts
  • KRMD’s stock price momentum as measured by its relative strength

About KORU Medical Systems, Inc. (KRMD)

Before we jump into KORU Medical Systems, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Want to learn more about KORU Medical Systems, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about KORU Medical Systems, Inc..

Learn More About A+ Investor

KORU Medical Systems, Inc.’s Stock Price as of Market Close

As of September 16, 2026, 4:00 PM, CST, KORU Medical Systems, Inc.’s stock price was $3.200.

KORU Medical Systems, Inc. is up 1.27% from its previous closing price of $3.160.

During the last market session, KORU Medical Systems, Inc.’s stock traded between $3.130 and $3.220. Currently, there are approximately 46.08 million shares outstanding for KORU Medical Systems, Inc..

KORU Medical Systems, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

KORU Medical Systems, Inc. Stock Price History

KORU Medical Systems, Inc.’s (KRMD) price is currently down 3.03% so far this month.

During the month of September, KORU Medical Systems, Inc.’s stock price has reached a high of $3.430 and a low of $3.090.

Over the last year, KORU Medical Systems, Inc. has hit prices as high as $6.608 and as low as $3.090. Year to date, KORU Medical Systems, Inc.’s stock is down 44.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused KORU Medical Systems, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 15, 2026, there were 0 analysts who downgraded KORU Medical Systems, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate KORU Medical Systems, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on KORU Medical Systems, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

KORU Medical Systems, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about KORU Medical Systems, Inc. (KRMD) by visiting AAII Stock Evaluator.

Relative Price Strength of KORU Medical Systems, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 15, 2026, KORU Medical Systems, Inc. has a weighted four-quarter relative price strength of -8.21%, which translates to a Momentum Score of 28 and is considered to be Weak.

Want to learn more about how KORU Medical Systems, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

KORU Medical Systems, Inc. Stock Price: Bottom Line

As of September 16, 2026, KORU Medical Systems, Inc.’s stock price is $3.200, which is up 1.27% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like KORU Medical Systems, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.